CA2251558A1 - Highly purified factor viii complex - Google Patents

Highly purified factor viii complex

Info

Publication number
CA2251558A1
CA2251558A1 CA002251558A CA2251558A CA2251558A1 CA 2251558 A1 CA2251558 A1 CA 2251558A1 CA 002251558 A CA002251558 A CA 002251558A CA 2251558 A CA2251558 A CA 2251558A CA 2251558 A1 CA2251558 A1 CA 2251558A1
Authority
CA
Canada
Prior art keywords
factor viii
highly purified
purified factor
viii complex
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002251558A
Other languages
French (fr)
Other versions
CA2251558C (en
Inventor
Wolfgang Schonhofer
Johann Eibl
Alfred Weber
Yendra Linnau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0066796A external-priority patent/AT403765B/en
Application filed by Individual filed Critical Individual
Publication of CA2251558A1 publication Critical patent/CA2251558A1/en
Application granted granted Critical
Publication of CA2251558C publication Critical patent/CA2251558C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

There is disclosed a highly purified complex comprising the components factor VIII and vWF having a specific activity of at least 70, preferably 100 to 300 U factor VIII:C/mg, a stable pharmaceutical preparation containing this complex as well as a method of producing the same.
CA002251558A 1996-04-12 1997-04-09 Highly purified factor viii complex Expired - Fee Related CA2251558C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0066796A AT403765B (en) 1996-04-12 1996-04-12 METHOD FOR PRODUCING A PREPARATION CONTAINING A HIGHLY CLEANED COMPLEX
ATA667/96 1996-04-12
PCT/AT1997/000069 WO1997039033A1 (en) 1996-04-12 1997-04-09 Purification of factor viii complex by immunoaffinity chromatography

Publications (2)

Publication Number Publication Date
CA2251558A1 true CA2251558A1 (en) 1997-10-23
CA2251558C CA2251558C (en) 2005-11-22

Family

ID=35474793

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002251558A Expired - Fee Related CA2251558C (en) 1996-04-12 1997-04-09 Highly purified factor viii complex

Country Status (1)

Country Link
CA (1) CA2251558C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579723B1 (en) 1997-02-27 2003-06-17 Baxter Aktiengesellschaft Method of recovering highly purified vWF or factor VIII/vWF-complex
US6831159B1 (en) 1997-02-27 2004-12-14 Baxter Aktiengesellschaft Method for purifying factor VIII/vWF company by cation-exchange chromatography

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579723B1 (en) 1997-02-27 2003-06-17 Baxter Aktiengesellschaft Method of recovering highly purified vWF or factor VIII/vWF-complex
US6831159B1 (en) 1997-02-27 2004-12-14 Baxter Aktiengesellschaft Method for purifying factor VIII/vWF company by cation-exchange chromatography
US6953837B2 (en) 1997-02-27 2005-10-11 Baxter Aktiengesellschaft Factor VIII/vWF complexes and compositions
US7648958B2 (en) 1997-02-27 2010-01-19 Baxter Innovations Gmbh Factor VIII/vWF-complex and methods of purifying same

Also Published As

Publication number Publication date
CA2251558C (en) 2005-11-22

Similar Documents

Publication Publication Date Title
CA2225601A1 (en) New stable pharmaceutical preparation for producing propellant-free aerosols
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
AU4942796A (en) Byproduct stream purification in the preparation of 1,3-propanediol-based polyesters
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
AU3167389A (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
AU6818196A (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
CA2152615A1 (en) Atovaquone pharmaceutical compositions
AU7001487A (en) Difluorohalomethoxyphenyl derivative and miticide comprising said derivative as active ingredient
AU9049391A (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
CA2100126A1 (en) 5,10-Methylenetetrahydrofolic Acid-Cyclodextrin Inclusion Compounds
AU5237396A (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
CA2179733A1 (en) Anticonvulsant pseudofructopyranose sulfamates
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
HUT50844A (en) Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient
AU7547787A (en) Dibenz(b,e)oxepin derivative and pharmaceutical containing the same as active ingredient
AU4093389A (en) Purification of 2,2-dichloro-1,1,1-trifluoroethane
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
EP0365678A4 (en) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF.
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
CA2251558A1 (en) Highly purified factor viii complex
AU3057989A (en) Esters of 3'-deaminodoxorubicin, liposomal compositions thereof
AU4946896A (en) Novel bi-tryptaminic derivatives, preparation process and utilization as drugs

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130409